Clinical trial

Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.

NCT04640935

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-10-01

PhaseN/A

Study timeline

Study start (actual)2019-10-01Date precision: day

Registry last updated2020-11-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

Sponsors & collaborators

Centre Hospitalier Annecy Genevoislead sponsor

University Hospital, Grenoblecollaborator

Mapped research locations

LyonFrance2 ParisFrance1 LilleFrance1 GrenobleFrance1 BrestFrance1 CréteilFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04640935 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.